— Know what they know.
Not Investment Advice

REMI OTC

Remedent, Inc.
1W: +0.0% 1M: +14.3% 3M: +14.3% YTD: +33.3% 1Y: +300.0% 3Y: -99.5% 5Y: -99.4%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Neutral · Power 63 · $15997 mcap · 13M float · 0.050% daily turnover · Short 98% of daily vol

Cash Flow Trends

Operating Cash Flow
-$131K -145.9% ▼
Capital Expenditures
$3 +0.0% ▲
Free Cash Flow
-$131K -145.9% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$62K +9.2% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$854K$10K$146K-$330K-$274K
Depreciation & Amort.$71K$36K$28K$25K$20K
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$559K-$59K-$402K$182K$38K
Other Non-Cash Items$326K$14K$59K$69K$86K
Operating Cash Flow$102K$2K-$169K-$53K-$131K
— Investing Activities —
Capital Expenditures$0$0$0$0$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$0$0$0
Investing Cash Flow$0$0$0$0$0
— Financing Activities —
Net Debt Issuance$0$0$0$0$0
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$0$0$0$0$0
Net Change in Cash$48K-$37K$96K-$68K-$62K
Cash End of Period$115K$78K$174K$105K$43K
Free Cash Flow$102K$2K-$169K-$53K-$131K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms